The Hindu Business Line : Dr Reddy's may exit Pathnet

DR Reddy's Laboratories Ltd has informed the stock exchanges that it has expressed its intention to Gribbles Pathology (VIC) Pty Ltd of Australia to exit the joint venture, Pathnet India Pvt Ltd.

Responding to the clarifications sought by the bourses on the press reports on the issue, Dr Reddy's Labs has, however, said it is neither negotiating with any buyers for its stake in this joint venture nor has it appointed any merchant banker for the purpose.

Dr Reddy's Labs has a 49 per cent holding in the joint venture with Gribbles.

More Stories on : Alliances & Joint Ventures | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Lodha challenges appointment of executors

IT spending by corporates low: Nasscom

IISCO to be merged with SAIL

Promoters' group cos buy AP Paper Mills shares

HPCL stalls ONGC bid to buy out Mangalore Refinery stake — Fears losing `strategic business interest'

Only way for IBP to survive is to merge with IOC: Chairman

BPCL weighing merger of KRL with itself

Cauvery Electrodes opens new unit

IOC to boost capacity at Paradip refinery

Kanoria Chem reaches financial closure for expansion plan

BT Broadcast Services in pact with DTH licencee

Biocon ties up with Novartis for contract research

Dr Reddy's may exit Pathnet

Ocimum ties up with Science Partners

Skoda plans 2 new models; launches turbo petrol engine car

Upadhyaya is new Nalco chief